Rollout of lateral flow testing devices for COVID-19 testing of asymptomatic patient-facing staff in primary care

 Asymptomatic staff self-testing using a Lateral Flow Device (LFD) will be offered to all general practice staff in the next 4-6 weeks on a voluntary basis . This type of testing aims to find asymptomatic cases of COVID 19 by testing patient facing practice staff regularly twice a week. Due to the relatively decreased sensitivity of LFDs compared to PCR, twice weekly testing is required. LFDs are point-of-care and deliver a result in 20mins. This approach to testing has been agreed with MHRA who have also approved the use of the Salesforce system to distribute lateral flow test kits to general practices for this purpose. The importance of this is that we know now that up to 1/3 of those infected with Covid display no symptoms but are infectious.